Abstract
Seventy-seven men with histologically proven and newly diagnosed prostate cancer we investigated for the presence of bcl-2 protein overexpression and p53 protein accumulation 1 immunohistochemistry. Forty-five men had evidence of locally advanced and metastatic disease and we treated by means of hormone manipulation. Twenty-eight patients either failed to respond to initial hormone manipulation or relapsed within 37 months from diagnosis (median 20 months). Of the 77 cancers, 37 (48% showed bcl-2 overexpression at diagnosis. Twenty-seven of those were treated with androgen ablation and 2 (74%) had hormone-refractory disease (P = 0.0128). Twenty-three of 77 men (29.8%) had nuclear staining for p53 protein. Twenty-one of those were treated with hormone manipulation and 14 (66.6%) showed hormone resistance (P = 0.0012). Seventeen patients had both bcl-2 overexpression and p53 protein accumulation, 16 of whom were hormonally treated, with 13 (81.2%) having hormone-refractory disease (P < 0.0001). These findings suggest that the combined detection of p53 protein accumulation and bcl-2 overexpression may be useful in predicting hormone resistance in prostate cancer. By deregulating programmed cell death, alteration in these genes may prevent patients from responding to androgen ablation, or allow them to escape hormonal control of the disease.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Apakama, I., Robinson, M., Walter, N. et al. bcl-2 overexpression combined with p53 protein accumulation correlates with hormone-refractory prostate cancer. Br J Cancer 74, 1258–1262 (1996). https://doi.org/10.1038/bjc.1996.526
Issue Date:
DOI: https://doi.org/10.1038/bjc.1996.526
- Springer Nature Limited
This article is cited by
-
Treatment of PC-3 cells with ultrasound combined with microbubbles induces distinct alterations in the expression of Bcl-2 and Bax
Chinese Science Bulletin (2013)
-
Molecular staging of prostate cancer in the year 2007
World Journal of Urology (2007)
-
Molecular mediators of cell death in multistep carcinogenesis: a path to targeted therapy
Cell Death & Differentiation (2006)
-
Apoptosis: mechanisms and implications for cancer therapeutics
Targeted Oncology (2006)
-
Drug Insight: use of docetaxel in prostate and urothelial cancers
Nature Clinical Practice Urology (2005)